Iwatsuki-Horimoto K - Search Results

1

Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma.

Maruki T, Nomoto H, Iwamoto N, Yamamoto K, Kurokawa M, Iwatsuki-Horimoto K, Yamayoshi S, Suzuki Y, Kawaoka Y, Ohmagari N. Maruki T, et al. Among authors: iwatsuki horimoto k. J Infect Chemother. 2024 Jan 17:S1341-321X(24)00012-6. doi: 10.1016/j.jiac.2024.01.008. Online ahead of print. J Infect Chemother. 2024. PMID: 38242284 Free article.

2

Identification of the porcine cytomegalovirus major capsid protein gene.

Rupasinghe V, Iwatsuki-Horimoto K, Sugii S, Horimoto T. Rupasinghe V, et al. J Vet Med Sci. 2001 Jun;63(6):609-18. doi: 10.1292/jvms.63.609. J Vet Med Sci. 2001. PMID: 11459006 Free article.

3

Analysis of porcine cytomegalovirus DNA polymerase by consensus primer PCR.

Rupasinghe V, Tajima T, Maeda K, Iwatsuki-Horimoto K, Sugii S, Horimoto T. Rupasinghe V, et al. J Vet Med Sci. 1999 Nov;61(11):1253-5. doi: 10.1292/jvms.61.1253. J Vet Med Sci. 1999. PMID: 10593586 Free article.

4

Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Hatta M, Goto H, Kawaoka Y. Horimoto T, et al. J Virol. 2003 Jul;77(14):8031-8. doi: 10.1128/jvi.77.14.8031-8038.2003. J Virol. 2003. PMID: 12829842 Free PMC article.

5

The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus.

Iwatsuki-Horimoto K, Kanazawa R, Sugii S, Kawaoka Y, Horimoto T. Iwatsuki-Horimoto K, et al. J Gen Virol. 2004 Apr;85(Pt 4):1001-1005. doi: 10.1099/vir.0.19519-0. J Gen Virol. 2004. PMID: 15039542

6

Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

Horimoto T, Fukuda N, Iwatsuki-Horimoto K, Guan Y, Lim W, Peiris M, Sugii S, Odagiri T, Tashiro M, Kawaoka Y. Horimoto T, et al. J Vet Med Sci. 2004 Mar;66(3):303-5. doi: 10.1292/jvms.66.303. J Vet Med Sci. 2004. PMID: 15107562

7

A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Kawaoka Y. Horimoto T, et al. Vaccine. 2004 Jun 2;22(17-18):2244-7. doi: 10.1016/j.vaccine.2003.11.019. Vaccine. 2004. PMID: 15149783

8

Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.

Horimoto T, Iwatsuki-Horimoto K, Hatta M, Kawaoka Y. Horimoto T, et al. Microbes Infect. 2004 May;6(6):579-83. doi: 10.1016/j.micinf.2004.02.011. Microbes Infect. 2004. PMID: 15158192 Free article.

9

Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence.

Iwatsuki-Horimoto K, Horimoto T, Fujii Y, Kawaoka Y. Iwatsuki-Horimoto K, et al. J Virol. 2004 Sep;78(18):10149-55. doi: 10.1128/JVI.78.18.10149-10155.2004. J Virol. 2004. PMID: 15331747 Free PMC article.

10

Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions.

Muramoto Y, Takada A, Fujii K, Noda T, Iwatsuki-Horimoto K, Watanabe S, Horimoto T, Kida H, Kawaoka Y. Muramoto Y, et al. J Virol. 2006 Mar;80(5):2318-25. doi: 10.1128/JVI.80.5.2318-2325.2006. J Virol. 2006. PMID: 16474138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page